Notices of Funding Opportunities That Allow Music-Based Interventions

Below is a list of current Notices of Funding Opportunities (NOFOs) that NCCIH participates in and that allow music-based interventions. 

• Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
• Notice of Special Interest: NCCIH Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development
• Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
• Notice of Special Interest (NOSI): Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (SBIR/STTR)
• Notice of Special Interest (NOSI): Fundamental Science Research on Complementary and Integrative Health Approaches, Including Natural Products or Mind and Body Interventions
• Notice of Special Interest: National Center for Complementary and Integrative Health (NCCIH) T32 Complementary and Integrative Health Practitioner Supplement Program for Pre- and Postdoctoral Candidates
• Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
• HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
• The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
• Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
• Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
• NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)
• Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)